Literature DB >> 24147552

Research status of the regulation of miRNA on BACE1.

Yanyao Deng1, Yu Ding, Deren Hou.   

Abstract

MicroRNAs (miRNAs) are noncoding RNAs that are around 22 nucleotides in length. miRNAs play a key role in neuronal development, differentiation, and synaptic plasticity. An increasing amount of evidence indicates that miRNAs regulate the expression of β-site APP cleaving enzyme (BACE1), a key enzyme in Alzheimer's disease (AD) pathology. Changes in miRNA expression as a causal factor in AD have not been fully elucidated. We hypothesized that the abnormal expression of miRNAs may contribute to AD pathology, specifically through the regulation of BACE1.

Entities:  

Keywords:  Alzheimer's disease; pathogenesis; β-amyloid

Mesh:

Substances:

Year:  2013        PMID: 24147552     DOI: 10.3109/00207454.2013.858249

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  4 in total

1.  Peripheral Blood MicroRNA Expression Profiles in Alzheimer's Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism.

Authors:  Ru-Jing Ren; Yong-Fang Zhang; Eric B Dammer; Yi Zhou; Li-Ling Wang; Xiao-Hong Liu; Bei-Lei Feng; Guo-Xin Jiang; Sheng-Di Chen; Gang Wang; Qi Cheng
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

2.  Is It the Twilight of BACE1 Inhibitors?

Authors:  Martina Hrabinova; Jaroslav Pejchal; Tomas Kucera; Daniel Jun; Monika Schmidt; Ondrej Soukup
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 3.  miRNAs as Therapeutic Tools in Alzheimer's Disease.

Authors:  Chang Youn Lee; In Soo Ryu; Jin-Hyeob Ryu; Hyun-Jeong Cho
Journal:  Int J Mol Sci       Date:  2021-12-01       Impact factor: 5.923

4.  Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Lin-Lin Wang; Li Min; Qing-Dong Guo; Jun-Xia Zhang; Hai-Lun Jiang; Shuai Shao; Jian-Guo Xing; Lin-Lin Yin; Jiang-Hong Liu; Rui Liu; Shui-Long Guo
Journal:  Biomed Res Int       Date:  2017-09-19       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.